JPMorgan Chase & Co. Purchases 6,073 Shares of Physicians Realty Trust (NYSE:DOC)

Share on StockTwits

JPMorgan Chase & Co. raised its stake in shares of Physicians Realty Trust (NYSE:DOC) by 1.9% in the first quarter, HoldingsChannel reports. The institutional investor owned 323,498 shares of the real estate investment trust’s stock after buying an additional 6,073 shares during the quarter. JPMorgan Chase & Co.’s holdings in Physicians Realty Trust were worth $6,085,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of DOC. Norges Bank purchased a new position in Physicians Realty Trust during the 4th quarter valued at about $35,906,000. Hudson Bay Capital Management LP purchased a new position in Physicians Realty Trust during the 4th quarter valued at about $11,808,000. Vanguard Group Inc grew its holdings in Physicians Realty Trust by 1.9% during the 3rd quarter. Vanguard Group Inc now owns 26,267,178 shares of the real estate investment trust’s stock valued at $442,864,000 after buying an additional 489,769 shares in the last quarter. Thrivent Financial for Lutherans grew its holdings in Physicians Realty Trust by 95.2% during the 4th quarter. Thrivent Financial for Lutherans now owns 935,178 shares of the real estate investment trust’s stock valued at $14,991,000 after buying an additional 456,152 shares in the last quarter. Finally, Peregrine Capital Management LLC purchased a new position in Physicians Realty Trust during the 1st quarter valued at about $7,545,000. 95.92% of the stock is owned by institutional investors and hedge funds.

A number of brokerages have recently issued reports on DOC. Zacks Investment Research upgraded Physicians Realty Trust from a “sell” rating to a “hold” rating in a research report on Monday, April 22nd. Capital One Financial downgraded Physicians Realty Trust from an “overweight” rating to an “equal weight” rating and set a $18.75 price target for the company. in a research report on Thursday, May 2nd. Finally, Morgan Stanley set a $19.00 price target on Physicians Realty Trust and gave the company a “hold” rating in a research report on Thursday, March 28th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $18.12.

In other news, insider John T. Thomas sold 5,000 shares of Physicians Realty Trust stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $18.26, for a total transaction of $91,300.00. Following the completion of the sale, the insider now owns 311,251 shares in the company, valued at approximately $5,683,443.26. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.62% of the company’s stock.

Shares of DOC opened at $18.17 on Friday. The stock has a market cap of $3.35 billion, a PE ratio of 16.82 and a beta of 0.55. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.66. Physicians Realty Trust has a 12-month low of $14.85 and a 12-month high of $19.16.

Physicians Realty Trust (NYSE:DOC) last issued its quarterly earnings results on Wednesday, May 1st. The real estate investment trust reported $0.25 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.26 by ($0.01). The business had revenue of $105.40 million for the quarter, compared to the consensus estimate of $104.27 million. Physicians Realty Trust had a net margin of 13.34% and a return on equity of 2.28%. The business’s revenue was up .2% compared to the same quarter last year. During the same quarter last year, the business posted $0.26 EPS. On average, equities analysts forecast that Physicians Realty Trust will post 1.06 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This piece of content was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright and trademark laws. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4371261/jpmorgan-chase-co-purchases-6073-shares-of-physicians-realty-trust-nysedoc.html.

Physicians Realty Trust Profile

Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company invests in real estate that is integral to providing high quality healthcare.

Recommended Story: What do investors mean by earnings per share?

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Physicians Realty Trust (NYSE:DOC).

Institutional Ownership by Quarter for Physicians Realty Trust (NYSE:DOC)

Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Alliance Data Systems Co.  Receives Average Rating of “Hold” from Brokerages
Alliance Data Systems Co. Receives Average Rating of “Hold” from Brokerages
Host Hotels and Resorts Inc  Receives Consensus Recommendation of “Buy” from Analysts
Host Hotels and Resorts Inc Receives Consensus Recommendation of “Buy” from Analysts
Weir Group PLC  Given Consensus Rating of “Buy” by Analysts
Weir Group PLC Given Consensus Rating of “Buy” by Analysts
ViaSat, Inc.  Receives $96.99 Average Target Price from Analysts
ViaSat, Inc. Receives $96.99 Average Target Price from Analysts
Carrefour SA  Given Consensus Rating of “Hold” by Brokerages
Carrefour SA Given Consensus Rating of “Hold” by Brokerages
RTL Group S.A.  Receives €53.23 Consensus Target Price from Analysts
RTL Group S.A. Receives €53.23 Consensus Target Price from Analysts


© 2006-2019 Ticker Report